IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, is pleased to announce that the Company has continued to see strong growth in revenue in the second half of the year. Growth has been accelerated by new and expanded contracts coming on line, deployment of newly developed algorithms and faster turnaround times in trial initiation. The Company is further able to confirm that it anticipates this improved revenue performance will drive additional operating leverage and the Board expects to build on the breakeven position reported at the half year.
Given the performance in the period to date, the Board anticipates that the results for the full year ending 30 September 2019 will be materially ahead of current market expectations.
Giulio Cerroni, Chief Executive Officer of IXICO, commented: “We are delighted to see continued momentum in our revenue growth, establishing 2019 as an inflexion point in the Company’s progress. This is a fantastic achievement which reflects the Company’s ability to support and grow with the increasing demand for our high quality neurological imaging and data analytics services.”
ixico